12,197 results on '"Pulmonary Surfactants"'
Search Results
2. Hidradenitis Suppurativa (HS) Tunneling Wounds
3. Non Inferiority Trial Investigating Surfactants Administered Via MIST (Niftisurf)
4. Surfactant-Mediated Structural Modulations to Planar, Amphiphilic Multilamellar Stacks.
5. Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease (RESPONSE)
6. Administration of Surfactant Through an Instillation Device Infasurf® (Calfactant) in Neonates- A Pilot Study
7. Early Bolus Surfactant Replacement Therapy Versus Standard Care in Term Neonates With Meconium Aspiration Syndrome
8. Surfactant Administration by Insure or Thin Catheter (SAINT)
9. Lung Surfactant Protein B Peptide Mimics Interact with the Human ACE2 Receptor.
10. Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm Infants (CaLI)
11. Implementing LISA Surfactant in Nigeria
12. The Budesonide in Babies (BiB) Trial (BiB)
13. Lung molecular and histological changes in type 2 diabetic rats and its improvement by high-intensity interval training
14. The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)
15. Lung molecular and histological changes in type 2 diabetic rats and its improvement by high-intensity interval training.
16. REspiratory MEchanics for Delivering Individualised Exogenous Surfactant (REMEDIES)
17. Comparison of INRECSURE and LISA in Preterm Neonates With RDS (INRECLISA)
18. Delivery Room Management Trial of Premature Infants at High Risk of Respiratory Distress Syndrome
19. Surfactant-Mediated Solubilization of Myelin Figures: A Multistep Morphological Cascade
20. Comparison of the efficacy of two natural surfactants (BERAKSURF and BLES) in the treatment of respiratory distress syndrome among preterm neonates
21. Surfactant Nebulization for the Early Aeration of the Preterm Lung (SUNSET)
22. Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease (STOPCLD)
23. Surfactant for Neonate With Acute Respiratory Distress Syndrome (ARDS)
24. Impact of Antenatal Corticosteroid Therapy on Postnatal Surfactant Use in Preterm Infants (CORISURF)
25. Surfactant for Neonatal Respiratory Distress Syndrome(NRDS) and Neonatal Acute Respiratory Distress Syndrome(NARDS)
26. Comparison of the efficacy of two natural surfactants (BERAKSURF and BLES) in the treatment of respiratory distress syndrome among preterm neonates.
27. Dynamic Properties of Pulmonary Lipid Monolayers on the Surfaces of Sodium Polystyrene Sulfonate and Polydiallyldimethylammonium Chloride Solutions.
28. Budesonide and surfactant combination for treatment of respiratory distress syndrome in preterm neonates and evaluation outcomes.
29. Emulation of the structure of the Saposin protein fold by a lung surfactant peptide construct of surfactant Protein B
30. SP-A binding to the SARS-CoV-2 spike protein using hybrid quantum and classical in silico modeling and molecular pruning by Quantum Approximate Optimization Algorithm (QAOA) Based MaxCut with ZDOCK
31. FOXO1 Couples KGF and PI-3K/AKT Signaling to NKX2.1-Regulated Differentiation of Alveolar Epithelial Cells
32. Budesonia + Intratracheal Surfactant in Incidence of Bronchopulmonary Dysplasia
33. LISA Catheter With Marked vs. Unmarked Tip in Extremely Low Birth Weight Infants With RDS
34. LISA Rigid Catheter vs LISA Soft Catheter in a Very Preterm Manikin
35. Structural and functional stability of the sulfur-free surfactant protein B peptide mimic B-YL in synthetic surfactant lipids.
36. Aerosol, chemical and physical properties of dry powder synthetic lung surfactant for noninvasive treatment of neonatal respiratory distress syndrome.
37. Surf early to higher tides: surfactant therapy to optimize tidal volume, lung recruitment, and iNO response
38. London's Exogenous Surfactant Study for COVID19 (LESSCOVID)
39. Prenatal inflammation enhances antenatal corticosteroid–induced fetal lung maturation
40. Evaluation of Semi-rigid and Flexible Catheters for Less Invasive Surfactant Administration in Preterm Infants
41. Aerosolized Surfactant in Neonatal RDS (AS-02)
42. Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19
43. Optimizing Exogenous Surfactant as a Pulmonary Delivery Vehicle for Chicken Cathelicidin-2
44. Neonatal ibuprofen exposure and bronchopulmonary dysplasia in extremely premature infants.
45. Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia (TOLSURF)
46. Exogenous Surfactant Through Nebulizer Mask on Clinical Outcomes in Covid-19 Patients (CovidSurf)
47. Interfacial rheology and direct imaging reveal domain-templated network formation in phospholipid monolayers penetrated by fibrinogen
48. Surfactant Replacement Guided by Early Lung Ultrasound Score in Preterm Newborns With Respiratory Distress Syndrome (ECHOSURF)
49. Surfactant for Neonatal Respiratory Distress Syndrome at High Altitude Areas:a Prospective Cohort Study
50. Use of budesonide associated with a pulmonary surfactant to prevent bronchopulmonary dysplasia in premature newborns - A systematic review.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.